loader2
Login Open ICICI 3-in-1 Account
Text Size
Text to Speech
Color Contrast
Pause Animations

Apr 10, 2026

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 35.93 8.50 13.66 35.30 0.04 44.95 35.66
Cipla Ltd 21.91 3.61 3.02 14.19 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 42.68 8.21 8.46 31.97 0.06 26.42 20.75
Dr Reddys Laboratories Ltd 18.62 3.15 2.86 12.66 0.11 23.05 18.53
Lupin Ltd 22.84 4.70 5.43 20.56 0.27 20.88 21.00
Torrent Pharmaceuticals Ltd 61.93 12.22 16.64 43.68 0.50 25.84 26.46
Ipca Laboratories Ltd 39.26 4.13 4.97 25.23 0.21 17.12 13.61
Sun Pharmaceutical Industries Ltd 36.25 7.55 5.10 25.69 0.04 19.52 16.16
Aurobindo Pharma Ltd 22.50 2.47 2.24 12.91 0.24 14.16 11.15
Wockhardt Ltd -2,167.82 7.25 4.78 77.31 0.57 3.87 -1.48
Ajanta Pharma Ltd 34.52 7.54 8.12 27.34 0.01 31.98 25.02
Gland Pharma Ltd 33.84 5.10 3.00 19.17 0.00 15.83 11.62
Biocon Ltd 89.85 3.70 1.49 20.76 0.84 6.86 6.90
Alkem Laboratories Ltd 26.85 5.02 4.87 26.54 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 57.31 4.58 6.37 34.44 0.22 18.48 15.79
Zydus Lifesciences Ltd 18.33 3.96 3.64 12.69 0.09 24.56 21.08
Divis Laboratories Ltd 65.53 17.36 10.53 53.84 0.00 20.42 15.35
Mankind Pharma Ltd 47.59 7.03 5.61 32.08 0.37 16.04 14.83
Laurus Labs Ltd 70.51 10.67 12.34 60.32 0.62 8.80 7.36
Piramal Pharma Ltd -118.78 2.12 2.40 19.97 0.60 6.43 1.14

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 67641.25
(2.0713%)
70833.65 59896.10
Nifty Bank 55912.75
(1.9902%)
61764.85 49954.85
Nifty 50 24050.60
(1.1588%)
26373.20 22182.55
Nifty 100 24809.80
(1.3203%)
26975.15 22720.45
BSE SmallCap 46825.31
(0.0%)
55792.26 45369.54
BSE Sensex 77550.25
(1.1987%)
86159.02 71545.81
BSE MidCap 44246.27
(0.0%)
47764.30 40742.39
BSE 100 25321.37
(1.2609%)
27621.72 23249.92

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

NSE accelerates order processing with nanosecond-level upgrade

The National Stock Exchange of India said it will enable nanosecond-level order acknowledgement across cu...

Apr 11, 2026 08:46
Muthoot Finance fixes record date for interim dividend

Muthoot Finance has fixed 17 April 2026 as record date for payment of interim dividend of Rs 30 per share...

Apr 10, 2026 18:08
NSE inks pact with S&P Global Energy for Platts-based derivatives

National Stock Exchange of India on 6 April 2026 announced a strategic collaboration with S&P Global Ener...

Apr 07, 2026 14:39
Aurobindo Pharma fixes record date for buyback of shares

Aurobindo Pharma has fixed 17 April 2026 as record date for the purpose of determining the entitlement an...

Apr 06, 2026 09:03
Automobile Products of India fixes record date for rights issue

Automobile Products of India has fixed 09 April 2026 as record date for rights issue. ...

Apr 04, 2026 13:29
NSE to roll out natural gas futures linked to IGX benchmark

The National Stock Exchange of India on 1 April 2026 announced a collaboration with Indian Gas Exchange t...

Apr 01, 2026 11:52
Disclaimer

ICICI Securities Ltd. Registered office of ICICI Securities is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. ICICI Securities is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.